Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Students made the dean’s list by achieving a grade point average of 3.5 or higher while carrying 9 credit hours or more for the semester.

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

Xavier high school honored legendary girls' basketball coach Tom Lilly during Friday night's game, celebrating his remarkable ...

Eli Lilly started 2024 on a strong note but struggled during the second half of the year. The drugmaker dealt with several ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

Financial writer recommends buying ARK Genomic Revolution ETF (ARKG) for potential growth in 2025. Explore more here.

Dean’s list, fall semester: Grace Askey, DuBois. SUSQUEHANNA UNIVERSITY, Selinsgrove — Dean’s list, fall semester: Alivia Nouse, Bedford; Steven Ressler, Bedford; Evan Forcey, Clearfield; Kayla Reed, ...

Tom Lilly Appreciation Night is another winning night for Cedar Rapids Xavier. Saints get a stern test from Cedar Rapids ...

The Danish drug company said an experimental weight-loss shot helped patients lose over one-fifth of their bodyweight. Novo's U.S. and [Europe-listed s ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...